UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

Immunity (Cambridge, Mass.), 2011-03, Vol.34 (3), p.375-384

2011

Volltextzugriff (PDF)

Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses

PloS one, 2015-11, Vol.10 (11), p.e0142035-e0142035

2015

Volltextzugriff (PDF)

Versatile virus-like particle carrier for epitope based vaccines

PloS one, 2010-03, Vol.5 (3), p.e9809-e9809

2010

Volltextzugriff (PDF)

Mechanisms of allergen-specific desensitization

Journal of allergy and clinical immunology, 2010-08, Vol.126 (2), p.375-383

2010

Volltextzugriff (PDF)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

The Journal of experimental medicine, 2009-08, Vol.206 (9), p.1941-1955

2009

Volltextzugriff (PDF)

Universal vaccine against influenza virus: Linking TLR signaling to anti‐viral protection

European journal of immunology, 2012-04, Vol.42 (4), p.863-869

2012

Volltextzugriff (PDF)

Isolation of human monoclonal antibodies by mammalian cell display

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (38), p.14336-14341

2008

Volltextzugriff (PDF)

Bacterially produced recombinant influenza vaccines based on virus-like particles

PloS one, 2013-11, Vol.8 (11), p.e78947-e78947

2013

Volltextzugriff (PDF)

Cystatin F is a biomarker of prion pathogenesis in mice

PloS one, 2017-02, Vol.12 (2), p.e0171923-e0171923

2017

Volltextzugriff (PDF)

Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses

The Journal of immunology (1950), 2009-09, Vol.183 (6), p.3788-3799

2009

Volltextzugriff (PDF)

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses

Proceedings of the National Academy of Sciences - PNAS, 2012-12, Vol.109 (50), p.20566-20571

2012

Volltextzugriff (PDF)

Vaccination against GIP for the treatment of obesity

PloS one, 2008-09, Vol.3 (9), p.e3163-e3163

2008

Volltextzugriff (PDF)

How Adeno-Associated Virus Rep78 Protein Arrests Cells Completely in S Phase

Proceedings of the National Academy of Sciences - PNAS, 2005-09, Vol.102 (38), p.13634-13639

2005

Volltextzugriff (PDF)

Cutting Edge: Identification of E-Cadherin as a Ligand for the Murine Killer Cell Lectin-Like Receptor G1

The Journal of immunology (1950), 2006-02, Vol.176 (3), p.1311-1315

2006

Volltextzugriff (PDF)

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein

Virology journal, 2009-12, Vol.6 (1), p.224-224, Article 224

2009

Volltextzugriff (PDF)

Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine

PloS one, 2013-10, Vol.8 (10), p.e76571

2013

Volltextzugriff (PDF)

Nanoparticles target distinct dendritic cell populations according to their size

European journal of immunology, 2008-05, Vol.38 (5), p.1404-1413

2008

Volltextzugriff (PDF)

Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles

The Journal of immunology (1950), 2009-05, Vol.182 (10), p.6261-6266

2009

Volltextzugriff (PDF)

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Molecular therapy, 2016-05, Vol.24 (5), p.1003-1012

2016

Volltextzugriff (PDF)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

Vaccine, 2010-07, Vol.28 (33), p.5503-5512

2010

Volltextzugriff (PDF)

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies

The Journal of immunology (1950), 2014-06, Vol.192 (12), p.5499-5508

2014

Volltextzugriff (PDF)

VSIG4, a B7 family-related protein, is a negative regulator of T cell activation

The Journal of clinical investigation, 2006-10, Vol.116 (10), p.2817-2826

2006

Volltextzugriff (PDF)

Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteins

BioTechniques, 2005-08, Vol.39 (2), p.209-212

2005

Volltextzugriff (PDF)

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

Frontiers in immunology, 2017-03, Vol.8, p.226-226

2017

Volltextzugriff (PDF)

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers

Vaccine, 2014-09, Vol.32 (39), p.5041-5048

2014

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(57)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Animals
(37)
Life Sciences & Biomedicine
(34)
Mice
(31)
Humans
(23)
Immunology
(21)
Mice, Inbred C57bl
(17)
Female
(14)
Male
(13)
Vaccines
(13)
Proteins
(12)
Multidisciplinary Sciences
(10)
Science & Technology - Other Topics
(10)
Antibodies
(9)
Antigens
(9)
Immunization
(9)
Biological And Medical Sciences
(8)
Biochemistry & Molecular Biology
(7)
Cell Line
(7)
Dendritic Cells - Immunology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses

Versatile virus-like particle carrier for epitope based vaccines

Mechanisms of allergen-specific desensitization

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

Universal vaccine against influenza virus: Linking TLR signaling to anti‐viral protection

Isolation of human monoclonal antibodies by mammalian cell display

Bacterially produced recombinant influenza vaccines based on virus-like particles

Cystatin F is a biomarker of prion pathogenesis in mice

Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses

Vaccination against GIP for the treatment of obesity

How Adeno-Associated Virus Rep78 Protein Arrests Cells Completely in S Phase

Cutting Edge: Identification of E-Cadherin as a Ligand for the Murine Killer Cell Lectin-Like Receptor G1

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein

Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine

Nanoparticles target distinct dendritic cell populations according to their size

Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies

VSIG4, a B7 family-related protein, is a negative regulator of T cell activation

Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteins

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers

Suchergebnisse filtern